Ciprofloxacin injections for skin sores from leishmaniasis
Treatments studied
Part of Infections, Skin clinical trials.
This study tests whether an injection of ciprofloxacin (an antibiotic) directly into skin sores can treat cutaneous leishmaniasis as effectively as the standard medicine, sodium stibogluconate. It may be an option if you have a small number of sores and have not been treated recently.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one or more skin sores from leishmaniasis, but fewer than seven sores.
- You have not had any treatment for leishmaniasis in the past month.
- You are not on long-term steroid therapy (like prednisone).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether injecting the antibiotic levofloxacin directly into sores caused by Leishmania parasites can help heal them. It might be an option if you have a few sores and haven't recently been treated for this infection.
This study tests if an injection of the antibiotic metronidazole directly into skin sores can help heal leishmaniasis, a parasite infection from sandfly bites. It's for people with fewer than seven sores.
This study tests whether applying a heat pack to skin sores caused by cutaneous leishmaniasis can help treat them. It's for people who cannot take the standard medication or prefer a non-drug option.
This study tests a gel containing miltefosine (a medicine) applied directly to the skin sores caused by cutaneous leishmaniasis. The goal is to see if the gel is safe and works to clear the sores.
This study tests if using heat therapy (thermotherapy) in local clinics is a good way to treat skin sores caused by leishmaniasis. It may be an option for people with a few small sores not on the face or near sensitive areas.
This study compares different drugs to find the best one for treating cutaneous leishmaniasis, a skin infection that causes sores. You might get one of several treatments, and the goal is to see which works best and is safest for patients like you.
Hear when a new Cutaneous Leishmaniasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.